Peter K.F. Chiu, MD, PhD, FRCSEd presented “The Baked Potato (Prostate): Focal Microwave Ablation” during the 2023 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on November 10, 2023, in Chicago, Illinois.
How to cite: Chiu, Peter K.F. “The Baked Potato (Prostate): Focal Microwave Ablation” November, 2023. Accessed Nov 2024. https://grandroundsinurology.com/the-baked-potato-prostate-focal-microwave-ablation/
The Baked Potato (Prostate): Focal Microwave Ablation – Summary
Peter K.F. Chiu, MD, PhD, FRCSEd, discusses the application and efficacy of focal microwave ablation (FMA) in the treatment of prostate cancer. Dr. Chiu emphasizes the minimally invasive procedure while emphasizing the precision of this method, which allows for effective ablation of cancerous lesions while minimizing damage to adjacent structures such as the urethra, neurovascular bundles, and rectum.
He describes the patients best suited for FMA and presents the procedure’s promising clinical outcomes. Dr. Chiu also addresses the technological advancements that have played a crucial role in enhancing FMA’s safety and effectiveness.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
ABOUT THE AUTHOR
Peter K. F. Chiu, MBChB, PhD (Erasmus), FRCSEd (Urol), graduated from the Faculty of Medicine of the Chinese University of Hong Kong (CUHK) and obtained a fellowship in urology from the College of Surgeons of Edinburgh. He received post-graduate training in prostate cancer research and andrology in the Erasmus Medical Centre in Rotterdam, The Netherlands, and obtained a PhD degree in prostate cancer diagnosis. Dr. Chiu is an Associate Professor in the Division of Urology in CUHK. He is the current President of the Hong Kong Urological Association (HKUA).
Dr. Chiu’s clinical practice and research focus is on prostate cancer, including prostate cancer screening, diagnosis with novel biomarkers (prostate health index, urine spermine), MRI-guided targeted prostate biopsy, and focal therapy. He utilizes HIFU, Cryotherapy, and Targeted microwave ablation (TMA) as focal therapy for prostate cancer. He also has special interest in managing patients with advanced prostate cancer with novel treatment options.
Dr. Chiu is a member of the prostate cancer working group of the European Association of Urology (EAU) Young Academic Urologists, and a council member of the Société Internationale d'Urologie (SIU) Academic Research Council and SIU Scientific Program Committee. He is a board member of the Hong Kong Kidney Foundation and editorial board member of the Asian Journal of Andrology and the International Journal of Urology. Dr. Chiu is also an associate editor for Frontiers in Surgery (Genitourinary Surgery) and Grand Rounds in Urology.
